Condition
Asperger Disorder
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
60.0%-27% vs avg
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
33.3%
2 terminated out of 6 trials
Success Rate
60.0%
-26.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results60% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (2)
Trial Status
Completed3
Terminated2
Unknown1
Trial Success Rate
60.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT02769949Completed
Pediatric Patients With Metabolic or Other Genetic Disorders
NCT02680015Not ApplicableUnknown
Understanding the Effects of Intervention on the Brain in Autism
NCT00965068Phase 1Completed
Cholesterol in ASD: Characterization and Treatment
NCT01983189Phase 2Terminated
Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism
NCT01553240Not ApplicableTerminated
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
NCT00251303Phase 2Completed
Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders
Showing all 6 trials